More Doctors Can Now Prescribe Buprenorphine to Opioid Users. Will It Help?news2023-03-03T08:00:11+00:00March 3rd, 2023|The New York Times|
New Approaches to the Drug Overdose Crisisnews2023-03-02T20:17:00+00:00March 2nd, 2023|The New York Times|
Opioid Distributors Cleared of Liability to Georgia Families Ravaged by Addictionnews2023-03-02T02:54:45+00:00March 2nd, 2023|The New York Times|
Biden Proposal Would Ban Online Prescribing of Certain Drugsnews2023-02-25T10:49:56+00:00February 25th, 2023|The New York Times|
Narcan Is Safe to Sell Over the Counter, Advisers to the FDA Concludenews2023-02-16T01:23:11+00:00February 16th, 2023|The New York Times|
Justice Dept. Sues AmerisourceBergen Over Role in Opioid Crisisnews2022-12-29T23:46:45+00:00December 29th, 2022|The New York Times|
Walmart Agrees to Pay $3.1 Billion to Settle Opioid Lawsuitsnews2022-11-15T19:30:25+00:00November 15th, 2022|The New York Times|
Medication Treatment for Addiction Is Shorter for Black and Hispanic Patients, Study Findsnews2022-11-09T17:28:16+00:00November 9th, 2022|The New York Times|
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlementnews2022-11-03T21:11:11+00:00November 3rd, 2022|The New York Times|
CVS and Walgreens Near $10 Billion Deal to Settle Opioid Casesnews2022-11-02T21:46:14+00:00November 2nd, 2022|The New York Times|
